Skip to main content
OpenTrials
Completed

NCT Number: NCT00168129

Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases

To assess the safety and efficacy of a single fraction of radiotherapy using helical tomotherapy to treat bone metastases.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bone Neoplasms Bone Diseases Musculoskeletal Diseases Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Cross Cancer Institute

Edmonton, Alberta, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • painful metastatic bone disease from any malignancy

Exclusion criteria

  • previous RT to same area
  • contraindications to RT

Treatment and study plan

Helical tomotherapy

Procedure

Primary outcomes

  1. To deliver a single fraction of radiotherapy safely to patients with bone metastases using helical tomotherapy

Secondary outcomes

  1. To assess and quantify the acute toxicity of patients with bone metastases treated with helical tomotherapy.

  2. To measure invivo dosimetry and compare delivered doses to computer-reconstructed dose distribution.

  3. To determine the maximum tolerated does of palliative radiation give with helical tomotherapy in a single fraction.

  4. To assess the efficacy (pain control) of radiotherapy given with helical tomotherapy.

Sponsors and collaborators

Lead sponsor

Alberta Health services

Other

Registry information

Important dates

Study start
2001
Study completion
2005
First posted
Sep 15, 2005
Registry last updated
Dec 9, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.